Welcome to Coulter Partners Global (English)

14 October 2024

Top hires for VC & PE portfolio companies Q3-2024

Search Highlights

Recent top global hires for Venture Capital and Private Equity portfolio companies, covering a broad range of disciplines and sectors across Life Sciences, Health and Tech.

This quarter’s successful placements include:

Function Focus area Location
CEO Small molecule biopharma Australia
CEO Medical devices Israel
CEO Nucleic acid therapies UK
CEO Neurostimulation devices Belgium
Chief Medical Officer Small molecule/ biologics platform US
Chief Discovery Officer Oncology platform technologies Austria
President EMEA Drug delivery systems Germany
VP, Head of Translational Development Gene writing tools Spain
VP, People Cardiac devices France
Site Head Plasma derived therapeutics US
Country General Manager Veterinary services Nordics
Commercial Director Patient monitoring solutions UK
Marketing & Communications Director AI for drug discovery France
Board Director Oncology focused biotech UK
Life Sciences Partner Investor Europe

Newly opened projects include:

Function Focus area Location
CEO Regenerative medicine UK
CEO Biomanufacturing Sweden
CEO Contract Research Organization France
Chief Business Officer Small molecule therapeutics Switzerland
Chief Financial Officer Antibody-drug conjugates Germany
Chief Operating Officer Outpatient services Switzerland
Chief Development Officer Cell reprogramming Sweden
Chief Medical Officer tRNA platform technologies US
VP, Head of Business Development Contract Development & Manufacturing Organization UK
Head of Global Sales Digital diagnostic devices Central & Eastern Europe
Head of Global Distribution Specialty pharma France
Country General Manager Remote patient monitoring UK
Global Marketing Director Surgical technologies US
Board Director Specialty ingredients Nordics
Chair Cardiac devices Israel

Related

A new version of Coulter Partners is available.